Company: GEHC
Filing Date: 2025-12-02
Form Type: 424B2
Source: 0001193125-25-305442
Chunk: 47

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-12-02
Form: 424B2
Chunk 47
---
200% of the principal amount of the 2028 notes and, in the case of the 2035 notes, of up to 0.350% of the principal amount of the 2035 notes. Any such securities dealers may resell any notes purchased from the underwriters to certain other brokers or dealers at a discount from the initial public offering price, in the case of the 2028 notes, of up to 0.150% of the principal amount of the 2028 notes and, in the case of the 2035 notes, of up to 0.250% of the principal amount of the 2035 notes. If all the notes are not sold at the initial public offering prices of the notes, the underwriters may change the offering prices of the notes and the other selling terms. The offering of the notes by the underwriters is subject to receipt and acceptance and subject to the underwriters’ right to reject any order in whole or in part. It is expected that delivery of the notes will be made against payment therefor on or about December 15, 2025, which is the tenth business day following the date of the pricing of the notes. Under Rule 15c6-1under the Exchange Act, trades in the secondary market generally are required to settle in one business day unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes prior to one business day before the settlement date will be required, by virtue of the fact that the notes initially will settle T+10, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement and should consult their own advisors. S-31

To the extent any underwriter that is not a U.S.-registered broker-dealer, such as Standard
Chartered Bank, intends to effect sales of notes in the United States, it will do so through one or more U.S.-registered broker-dealers in accordance with the applicable U.S. securities laws and regulations and the rules of the Financial Industry
Regulatory Authority, Inc. (“FINRA”).

Each series of the notes is a new issue of securities with no established trading
market. The underwriters have advised us that they currently intend to make markets in the notes. The underwriters, however, are not obligated to do so, and any market-making activity with respect to the notes may be discontinued at any time without
notice.

In connection with the offering, the underwriters may purchase and sell notes in the open market